MK0663, etoricoxib / Duration of Treatment: 4 weeks

DRUG2 trials

Sponsors

Organon and Co

Conditions

Bone NeoplasmsChronic Low Back Pain

Phase 2

Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)

WithdrawnNCT00095017

Organon and CoBone Neoplasms

Start: 2004-11-30Updated: 2022-02-16

Phase 4

Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)

CompletedNCT00090181

Organon and CoChronic Low Back Pain

Start: 2004-06-30End: 2005-03-31Updated: 2022-02-15